Sensor-verified dose data. Without changing how patients live or how sites operate.
Two scenarios. Same week — three ways: what actually happened, what a proxy monitor records, and what MyAide measures at the dose level.
Dose taper failure.
2 tablets daily days 1–5, 1 tablet daily days 6–7. Patient does not taper.
Proxy monitor
Taper failure invisible. Full compliance reported.
MyAide
Overdose flagged days 6–7. Clinician alerted before day 8.
Ointment underapplied.
4 ftu daily. Patient dispensed 2 ftu most days. 8 ftu one day.
Proxy monitor
All seven days recorded as container opened.
MyAide
6 under and 1 over-dispense detected.
Measured to 0.15g accuracy.
Phase 2–4 sponsors and CROs that need adherence data able to withstand regulatory scrutiny. Across oral, topical, and other dosage forms.
For sponsors and CROs →Real-world evidence and outcomes research teams connecting medication behavior to PASI, A1c, or therapy response — with a precision claims data cannot support.
For Medical Affairs →Transplant, oncology, dermatology, and complex therapy programs where dose-level precision is the difference between a useful signal and a guess.
For specialty programs →The MyAide Platform
Sensor-verified dose data captured at the point of dispense, processed through clinical models, and delivered as decision-grade evidence to the people who act on it.
MyAide™ is a measurement platform built to capture precise quantities of medication dispensed, at the moment of dispense, across dosage forms, in the patient’s own hands. The same architecture works whether the container is a pharmacy vial, an ointment tube, a foam dispenser, or a liquid bottle. Smart Dock and Smart Cap are the two form factors in service today. The platform is protected by multiple issued patents across nine countries and has been deployed across thousands of patient days and multiple patient cohorts.
Solid-oral · Vials · Tablets · Capsules
Configurable for a range of pharmacy vials and medication containers. Measures the amount of medication dispensed at each dose event, and converts that to the number of tablets or capsules removed. Works with oral solids, foams, and gels. NFC detects vial presence with >99% accuracy. Bluetooth and Wi-Fi connected. Patient app optional.
Topical · Tubes · Creams · Ointments · Foams
Fits over standard ointment tubes, foam dispensers, and liquid bottles. Quantifies medication dispensed by mass plus time and temperature at sub-fingertip-unit precision. The first device to make topical and liquid adherence measurable in real-world settings.
Mobile · iOS & Android · Two-way engagement
The patient-facing layer for iOS and Android. Pairs with Smart Dock and Smart Cap to close the loop between device and patient, delivering reminders before a dose is due and alerts when a dose is missed, overdue, or outside the prescribed amount. Patients receive immediate confirmation of each dose and are alerted when a dispense falls outside the prescribed amount, giving them the information to correct and stay on track.
Two-way engagement means patients are not just monitored — they are supported. Every interaction is logged and surfaced to the clinical dashboard automatically.
iOS & Android — pairs with Smart Dock and Smart Cap
Web platform
Clinician- and sponsor-facing. Cohort visualizations, configurable alerts, raw-data export, and the on-target / overdose / underdose timeline view — impossible to produce with any proxy-event system, because MyAide measures quantity, not events.
Request a dashboard walkthrough →The device sits where the medication sits. The patient changes nothing. The data moves automatically. MyAide™ was designed to minimize effort and hassle for patients, sites, and clinicians.
Patient cohorts are enrolled through the admin module
A dedicated login configures each patient’s device and app with their specific regimen (medications, dosing schedule, and instructions) before the device ships.
The patient receives their medication and Smart Dock or Smart Cap
The device arrives ready to use with a brief onboarding process, either done by the patient or with minimal supervision. Apps are pre-configured and connected.
Each dispensing event is weighed and recorded
The smart devices capture the amount of the dose dispensed in dose-specific units (tablets, fingertip units, teaspoons, drops), and patients receive immediate confirmation.
Data transmits to the MyAide platform in real time
Measurements are sent via Bluetooth or Wi-Fi to the cloud, where they are timestamped, validated, and stored in a structured, analysis-ready format.
MyAide AI generates personalized patient engagement
The platform interprets the patient’s dispensing pattern and delivers timely, tailored messages reinforcing adherence, flagging interruptions, and adapting over time.
Clinicians and care teams monitor in the dashboard
Authorized users see each patient’s dispensing history, trends, and alerts, without asking the patient to report, estimate, or recall.
Sponsors and investigators access structured study data
For clinical trials, the platform exports CDISC-compliant records of actual quantity dispensed per patient, per dose event, traceable and defensible in protocol-deviation review and primary endpoint analyses.
The measurement record travels with the study, not the device
At study close or prescription end, the data remains complete, auditable, and ready to support publication, regulatory submission, or outcomes analysis.
The intelligence layer is where dose data becomes clinical action. It identifies patterns, surfaces emerging concerns, supports timely outreach to patients, and equips clinicians with context for the moments that matter — all on a foundation that proxy-based systems cannot offer.
Responses are generated under the MyAide AI Constitution, drawing on three foundations: Anthropic’s constitutional AI methodology, the AMA Code of Medical Ethics, and a trustworthiness framework derived from the foundational consumer trust and accountability research of our founding team.
Operationally, the system uses retrieval-augmented generation over a curated clinical knowledge base, with explicit retrieval confidence thresholds and a structured self-evaluation loop that runs before every response.
The substrate underneath is what makes the intelligence layer different. Sensal generates a continuous stream of electronic, quantity-resolved, time-stamped dose evidence, captured alongside concurrent patient context and clinical context. This is the data on which the intelligence learns, and it is unique to platforms that measure dose quantity rather than infer it.
The constitutional layer governs how that learning translates into agent behavior. The data layer determines what the agent has to work with in the first place.
Three common dosing error scenarios. Each panel shows a seven-day window: what actually happened, what a proxy monitor records, and what MyAide measures at the dose level.
Weekly Pillbox Decanting.
Patient decants a week's pills Sunday morning. Bottle is not opened again all week.
Proxy monitor
One cap-open event. Six days recorded as missed. No action taken.
MyAide
Bulk removal detected. No subsequent doses confirmed. Patient outreach triggered.
Diary Says Applied. Foam Says Otherwise.
Days 2 and 5 fully missed — patient logs "applied" in the e-diary both days.
Proxy monitor
Full-week compliance recorded. Both missed doses invisible.
MyAide
2 missed doses confirmed. Compliance rate: 71%, not 100%.
Two Prescribed. One Removed.
Two tablets per dose event prescribed. Patient consistently removes only one every day.
Proxy monitor
Seven compliant events recorded. Dose quantity not measured.
MyAide
1 tablet removed where 2 prescribed · every day · 50% of prescribed dose delivered.
Smart Dock, Smart Cap, and MyAide are deployed today, generating dispense-level records across solid oral and topical dosage forms, validated independently at Wake Forest and the University of Houston.
Sensor-verified, quantity-level dose data across solid-oral, topical, and liquid forms. The input your evidence, protocol, and program decisions rest on.
Pharma · Medical Affairs & HEOR
Real-world adherence data generated from proxy-event sensors carries an interpretive footnote in every analysis. Quantity-level data does not. MyAide produces a measurement record that can be cleanly stratified, modeled, and defended in HEOR analyses, registries, post-authorization safety studies, and label-expansion evidence packages.
The downstream effect on the analysis itself is substantial. Quantity-level data supports clean stratification by adherence quartile, defensible dose-response and exposure-response modeling, and persistence curves built on what patients actually took rather than what a cap opening implied. For evidence packages that go to payers, regulators, or formulary committees, the difference is whether adherence appears as a confounder to be hedged against or as a variable that strengthens the argument.
Use cases
Clinical Trials & CROs
Bluetooth and WiFi-connected hardware, no patient app required, and a sponsor dashboard that delivers the data directly. Validated to 100% pill-count agreement and 99% time-of-administration accuracy, defensible in protocol-deviation review and primary-endpoint sensitivity analyses, with CDISC/SDTM-compliant output.
One device on the patient’s countertop, no app for sites to support, and no separate data stream for the CRA to reconcile. Bluetooth and WiFi avoid the IT and consent friction that cellular devices create, and the sponsor sees the same record the site sees.
Specialty Pharmacy & Health Systems
MyAide flags partial doses, missed doses, late doses, and double doses at the patient level, not month-end claims aggregates. Clinical pharmacists can intervene during the actual gap, not after a refill has lapsed.
Use cases
RPM Platforms & Adherence Coaching
RPM platforms monitor vitals. Adherence coaching motivates behavior. Neither answers the question that drives the residual variation in every outcomes dataset: did the patient actually take the medication. MyAide closes that gap with a verified compliance variable.
Integration architecture
Dermatology · Pharma & Trials
Sensal is the only adherence platform with validated measurement across the full range of dermatology dosage forms: oral solids on the Smart Dock, and foams, gels, creams, and ointments on the Smart Cap and Smart Dock. Patients have used the technology as part of their daily routine without changing how they apply or take medication, and the platform captures how much was dispensed at each use and when. The result is a clean quantity-level adherence record for sponsors evaluating biologics-versus-topicals positioning, for trials where topical arms have historically been weakened by uncertain adherence, and for specialty programs supporting psoriasis, atopic dermatitis, and acne.
Use cases
Across trials, medical affairs, specialty pharmacy, RPM, and dermatology — Sensal delivers a measurement-grade adherence record where proxy data falls short.
Resources
Monitoring adherence to vulvar lichen sclerosus treatment, a prospective study
Validation of the Sensal Health MyAide™ Smart Dock Medication Adherence Device
Happy Holidays: A reduction in topical medication adherence during the winter holidays
Validation of the Sensal Health Smart Dock™ Medication Adherence Device
Assessing the adherence and clinical outcomes of using multiple topical acne products vs. a single combination product
Patients with vulvar lichen sclerosus prioritize education
Sensal Smart Cap topical Validation
Validation of Sensal Smart Dock
Shifting the paradigm of dermatology medication management
Shifting the paradigm of Virtual management
Sensal Health MyAide™ Smart Cap
Sensal Health MyAide™ Smart Dock
About
Direct measurement for the therapies that matter most.
Sensal Health is a medication intelligence company. MyAide, our platform, gives clinicians, sponsors, and care teams a direct signal of what was actually dispensed — not inferred, not self-reported, not estimated from refills. We built it for the therapies where that distinction matters most, and for the people responsible for getting them right.
The company is led by pharmacists, clinicians, and researchers whose prior work spans drug delivery, dermatology, behavioral adherence science, and the dynamics of patient accountability and trust.
Sentinel, the guardian, alert to what matters and ready to act on it. Salubrious, health-giving, the restoration of well-being. Together they describe what the best medications are meant to be, and what the people who dispense them, pharmacists, clinicians, care teams, work every day to deliver.
Sensal was built on our conviction that medication management could be genuinely impactful, for patients living with chronic and complex therapies, and for the clinicians responsible for their outcomes. Building toward that meant moving past where the field had stopped. It meant innovation that could leapfrog existing solutions rather than incrementally improve them. It meant hardware and software built to be robust enough for daily use across formats, simple enough for patients to live with, and validated independently enough to stand up in peer-reviewed evidence. None of that was fast. It is what we believed the vision required.
The Sensal Health team combines experience across pharmacy (clinical, behavioral, retail, manufacturing, formulation, regulatory, specialty), medical practice (dermatology and primary care), engineering (hardware, software, user-centered design), consumer trust research, program management, and the commercialization of healthcare technology.
Leadership
%20(1).jpg)
.jpg)
Senior advisors
%20(1).jpg)
Medical
Primary Care Physician, Duke Health (Retd)
Blog
Research perspectives, clinical commentary, and thinking on medication adherence from the Sensal team.
Why explainable AI alone is not enough to earn patient trust in health AI systems. A closer look at the relational, cognitive, and contextual factors that actually drive whether patients trust clinical AI — and what builders need to understand beyond model transparency.
Strong Patient Trust in Clinicians Must Be Protected from Damage, Whether Intentional or Not
Multiple recent surveys provide converging evidence that patient trust in clinicians is still as strong as ever.
Trust in Healthcare AI Can Be Hurt — Intentionally or Innocuously
How trust in clinical AI is fragile and easily eroded, even without malicious intent.
Building Relational Slack With Patients
The relational reserve clinicians build with patients — and how it absorbs the inevitable strains of care.
Patient Trust Is Not Just About Care — It's Also About Caring
Trust isn't only about clinical competence. It's also about whether patients feel cared for.
Telehealth's "virtual-first" approach flamed out. Now comes the "virtual second" refresh.
A First Opinion essay arguing that telehealth's next chapter belongs to a "virtual second" model — deeper interventions, credible outcomes, and a pragmatic alternative to virtual-first care.
Will General Catalyst's Health Assurance Transformation Corporation (HATCo) Model Work in 2024?
A look at General Catalyst's health assurance model — a bold vision paired with a pragmatic approach focused on seamless changes and aligning stakeholder incentives.
Patient 'Care' Key to Satisfaction
Patient satisfaction in dermatology hinges less on clinical outcomes than on whether patients feel cared for.
Send a message
Legal
Last updated: May 2026
By accessing or using the Sensal Health website and services, you agree to be bound by these Terms of Use. If you do not agree to these terms, please do not use our services.
The Sensal Health platform and associated services are intended for use by healthcare professionals, clinical researchers, and authorised institutional users. You agree to use our services only for lawful purposes and in accordance with applicable regulations, including those governing the use of medical devices and health data.
All content, technology, and materials on this site — including the MyAide platform, Smart Dock, Smart Cap, and associated software — are the intellectual property of Sensal Health, Inc. and are protected by applicable patent, copyright, and trademark law. Unauthorised reproduction or use is strictly prohibited.
The information provided on this website is for informational purposes only and does not constitute medical advice. Sensal Health's products are intended to support clinical decision-making and research — not to replace the professional judgment of qualified healthcare providers.
To the fullest extent permitted by law, Sensal Health, Inc. shall not be liable for any indirect, incidental, special, or consequential damages arising from the use of, or inability to use, our services or products.
We reserve the right to update these Terms of Use at any time. Continued use of our services following any changes constitutes acceptance of the revised terms.
For questions about these terms, please contact us at info@sensalhealth.com.
Legal
Last updated: May 2026
We collect information you provide directly to us, such as when you contact us through our website, request a demo, or engage with our platform. This may include your name, email address, organisation, and the nature of your inquiry.
We also collect certain technical information automatically, including IP addresses, browser type, and pages visited, to improve the performance and security of our website.
We use the information we collect to respond to inquiries, provide and improve our services, send relevant communications with your consent, and comply with legal obligations. We do not sell your personal information to third parties.
Sensal Health's platform is designed to process medication adherence data within regulated clinical and research frameworks. All patient data collected through the MyAide platform is handled in accordance with applicable health data regulations, including HIPAA where applicable, and is never used for commercial purposes beyond the scope of the relevant study or program.
We implement industry-standard security measures to protect your information against unauthorised access, alteration, disclosure, or destruction. Data transmitted through our platform is encrypted in transit and at rest.
Our website uses cookies to improve user experience and analyse site traffic. You may adjust your browser settings to refuse cookies, though some functionality may be affected as a result.
Depending on your jurisdiction, you may have the right to access, correct, or request deletion of personal information we hold about you. To exercise these rights, please contact us at info@sensalhealth.com.
We may update this Privacy Policy from time to time. Any changes will be posted on this page with an updated revision date.
For privacy-related questions, please contact info@sensalhealth.com.
.jpg)
.jpg)
